The in vivo significance of antibiotic induced endotoxin release in experimental Gram-negative sepsis

Journal of Endotoxin Research

Volumn 3, Issue 3, 1996, Pages 245-252

  Opal, S M ^a   Horn, D L ^b   Palardy, J E ^b   Parejo, N ^b   Jhung, J ^b   Bhattacharjee, A ^b   Young, L D ^b  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; ENDOTOXIN; GALACTOSAMINE; IMIPENEM; PENICILLIN BINDING PROTEIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTEREMIA; BACTERIOLYSIS; CONFERENCE PAPER; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; LETHALITY; NONHUMAN; PERITONEAL FLUID; PSEUDOMONAS AERUGINOSA; RAT;

ANIMALIA; BACILLI; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0029738667     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300310     Document Type: Conference Paper

References (22)

1. Prins J.M., vanDeventer S.J.H., Kuijper E.J., Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211-1218.
2. Buxton Hopkin D.A. Frapper fort ou frapper doucement: a Gram-negative dilemma. Lancet 1978; ii: 1193-1194.
3. Hurley J.C. Antibiotic-induced release of endotoxin: A reappraisal. Clin Infect Dis 1992; 15: 840-854.
4. Evans M.E., Pollack M. Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J Infect Dis 1993; 167: 1336-1343.
5. Leeson M.C., Fujihara Y., Morrison D.C. Evidence for lipopolysaccharide (LPS) as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria. Infect Immun 1994; 62: 4975-4980.
6. Jackson J.J., Kropp H. Beta-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP)-2-specific imipenem with PBP-3-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
7. Dofferhoff A.S.M., Nijland J.H., deVries-Hospers G.H., Mulder P.O.M., Weits J., Bom V.J.J. Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in-vitro and in-vivo study. Scand J Infect Dis 1991; 23: 745-754.
8. Dofferhoff A.S.M., Potthoff H., Bom V.J.J. et al. Release of endotoxin, TNF and IL-6 during the antibiotic treatment of experimental Gram-negative sepsis. J Endotoxin Res 1995; 2: 37-44.
9. Bucklin S.E., Morrison D.C. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of Gram-negative sepsis. J Infect Dis 1995; 172: 1519-1527.
10. Opal S.M., Marra M.N., McKelligan B., Fisher C.J., Palardy J.E., Scott R.W. Relative concentrations of endogenous endotoxin binding proteins in infected body fluids. Lancet 1994; 344: 429-431.
11. Cross A.S., Opal S.M., Sadoff J.C., Gemski P. Choice of bacteria in animal models of sepsis. Infect Immun 1993; 61: 2741-2747.
12. Heumann D., Galley P., Betz-Corradin S., Barras C., Baumgartner J-D., Glauser M.P. Competition between bactericidal/permeability-increasing and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes. J Infect Dis 1993; 176: 1351-1357.
13. Ostergaard B.E., Lakatua D., Rotschafer J.C. Assays for antimicrobial agents in body fluids. In: Murray P.C., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H. (Eds) Manual of Clinical Microbiology, 6th Edn. Washington, DC: American Society for Microbiology Publications, 1995; 1428-1435.
14. Reed L.J., Muench H. A simple method for estimating fifty-percent end-points. Am J Hygiene 1938; 27: 493-497.
15. Cross A.S., Sadoff J.C., Kelly N.M., Bernton E.W., Gemski P. Pretreatment with recombinant murine tumor necrosis factor-alpha/cachectin and murine interleukin-1 alpha protects mice from lethal bacterial infection. J Exp Med 1989; 165: 2021-2027.
16. Eng R.H.K., Smith S.M., Fan-Havard P., Ogbara T. Effect of antibiotics on endotoxin release from Gram-negative bacteria. Diagn Microbiol Infect Dis 1993; 16: 185-189.
17. Shenep J.L., Flynn P.M., Barrett F.F., Stidham G.L., Westenkirckner D.F. Serial quantitation of endotoxemia and bacteremia during therapy for Gram-negative sepsis. J Infect Dis 1988; 157: 565-568.
18. Shenep J.L., Barton R.P., Mogan K.A. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012-1018.
19. Cohen J., McConnell J.S. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur J Clin Microbiol 1986; 5: 13-17.
20. Simon D.M., Koenig G., Trenholme G.M. Differences in release of TNF from THP-1 cells stimulated by filtrates of antibiotic-killed E. coll. J Infect Dis 1991; 164: 800-802.
21. Opal S.M. Lessons learned from clinical trials of sepsis. J Endotoxin Res 1995; 2: 221-226.
22. Artenstein A.W., Cross A.S. Inhibition of endotoxin reactivity by aminoglycosides. J Antimicrob Chemother 1989; 24: 826-828.